Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Gentamicin sulfate
Advanz Pharma
J01GB03
Gentamicin sulfate
40mg/1ml
Solution for injection
Intravenous; Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010400; GTIN: 5060064171691
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Gentamicin 40mg/ml Solution for Injection is and what it is used for 2. What you need to know before you are given Gentamicin 40mg/ml Solution for Injection 3. How you will be given Gentamicin 40mg/ml Solution for Injection 4. Possible side effects 5. How to store Gentamicin 40mg/ml Solution for Injection 6. Contents of the pack and other information 1. WHAT GENTAMICIN 40MG/ML SOLUTION FOR INJECTION IS AND WHAT IT IS USED FOR The name of your medicine is Gentamicin 40mg/ml Solution for Injection. Gentamicin 40mg/ml Solution for Injection contains the active ingredient gentamicin which belongs to a group of medicines called antibiotics. Gentamicin 40mg/ml Solution for Injection is used in adults and children to treat bacterial infections such as severe chest infections, urinary tract infections and septicaemia. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN GENTAMICIN 40MG/ML SOLUTION FOR INJECTION YOU SHOULD NOT BE GIVEN Gentamicin 40mg/ml Solution for Injection: • if you are ALLERGIC to gentamicin or a similar medicine containing an aminoglycoside antibiotic, or any of the other ingredients of this medicine, (listed in section 6). • if you suffer from MYASTHENIA GRAVIS, a disease causing muscle weakness WARNINGS AND PRECAUTIONS Talk to your doctor or nurse before being given Gentamicin 40mg/ml Solution for Injection: • if you have any problems with your kidneys, liver or hearing • if you have any infections or a fever • if you have low blood pressure or low blood volume • if you are considered to be significantly overweight • if you have Parkinson’s disease or any other disease causing muscle Read the complete document
OBJECT 1 GENTICIN (GENTAMICIN) 40MG/ML INJECTABLE Summary of Product Characteristics Updated 24-Apr-2018 | Concordia International - formerly AMCo 1. Name of the medicinal product Genticin Injectable Gentamicin 40 mg/ml Solution for Injection 2. Qualitative and quantitative composition Each ampoule (2 ml) contains Gentamicin Sulphate equivalent to 80 mg Gentamicin base. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection. Each ampoule contains a sterile, clear, colourless solution. The solution is preservative free. 4. Clinical particulars 4.1 Therapeutic indications Gentamicin is indicated in adolescents, children and adults for the following: The treatment of systemic infections due to susceptible bacteria such as, bacteraemia, septicaemia, urinary-tract infections and severe chest infections. Consideration should be given to official local guidance on the appropriate use of antibacterial agents. 4.2 Posology and method of administration Posology Adults The daily recommended dose in adults with normal renal function is 3-6mg/kg body weight per day as one (preferred) up to two single doses. Serious infections In life-threatening infections the frequency of dosage may need to be increased to 6-hourly and the quantity of each dose may also be increased at the discretion of the clinician up to a total dosage of 5mg/kg in 24 hours. In such cases it is advisable to monitor gentamicin serum levels. If renal function is not impaired, 160mg once daily may be used in some cases. Renal impairment In cases of impaired renal function a reduction in dosage frequency is recommended. The following table is a guide to recommended dosage schedules: Blood urea (mg/100ml) Creatinine clearance (GFR) (ml/min) Dose and frequency of administration <40 40 - 100 100 - 200 >200 Twice-weekly intermittent haemodialysis >70 30 - 70 10 - 30 5 - 10 <5 80mg† 8-hourly 80mg† 12-hourly 80mg† daily 80mg† every 48 hours 80mg† after dialysis † 60mg if body weight <60kg Paediatric population: Th Read the complete document